Inactive Instrument

Highlights Regnum Corp. Other OTC

Equities

RGMP

US75915R1068

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Regnum Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Martin Shkreli-founded drug company files for bankruptcy	23-05-10	RE
Regnum Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
Regnum Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Regnum Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Regnum Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Regnum Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI
Regnum Signs Assignment and Assumption Agreement with CytoDyn and SevenScore Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV	22-01-10	CI
Regnum Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-23	CI
SevenScore Pharmaceuticals, LLC cancelled the acquisition of Regnum Corp. from Phoenixus AG in a reverse merger transaction.	21-08-31	CI
Regnum Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-08-13	CI
SevenScore Pharmaceuticals LLC entered into an agreement to acquire Regnum Corp. in a reverse merger transaction for $9.8 million.	21-04-08	CI
Regnum Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	21-02-03	CI
Regnum Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-10-13	CI
Regnum Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-29	CI
Regnum Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-14	CI
Regnum Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-05	CI
Regnum Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-07-25	CI
Regnum Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-14	CI
Regnum Corp. has completed an IPO in the amount of $0.0295 million.	19-04-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Regnum Corp. Other OTC

Equities

RGMP

US75915R1068

Highlights

Filters